About FHH
History
Organizational structure
- Standing Committee
- Sub-Committee
Ex-Chairperson
Members List
Photos
Bulletin Board
Information
Notice
Short Communications
Adulterated Herbal Medicine
- Purpose
- Database
Herbs World Wide
Meetings
Standing Committee
International Symposium
Meeting Materials
Sub-Committee 1
Sub-Committee 2
Sub-Committee 3
FHH Previous Meeting
Projects
Pharmacopoeia
- Purpose
- Products
- Terminology
- Link
FHH Atlas
FHH RMPM
- Purpose
- Results
- Distribution
COVID-19
COVID-19
Link
Link
Sign In
About FHH
History
Organizational structure
Ex-Chairperson
Members List
Photos
History
History
Organizational structure
Ex-Chairperson
Members List
Photos
Meetings
게시물 검색폼
Keyword
ADR
Adulteration
Aflatoxin
Benzopyrene
CITES
Collaboration
DNA
Efficacy
GA(C)P
GMP
Guideline
Heavy metal
Microorganism
Pesticide
Pharmacopoeia
Processing
Quality
Reference substance
Regulation
Registration
Safety
Sulfur dioxide
Surveillance
Training
Year
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
[Total :
709
]
No.
Code
Title
Speaker
Country
214
4th FIS 05 (2010)
Risk detection in health products regulation
Belinda TAN
Singapore
213
4th FIS 04 (2010)
MHPD post-market surveillance, natural health products
Duc VU
Canada
212
4th FIS 03 (2010)
Ginsenoside Rg3-induced apoptosis in human lung adenocarcinoma
Yeong-Shik KIM
Republic of Korea
211
4th FIS 02 (2010)
Introduction of the chinese pharmacopoeia(2010 version volume 1)
Ruichao LIN
China
210
4th FIS 01 (2010)
New development in herbal medicines
Narantuya SAMDAN
WHO WPRO
209
8th FSC 19 (2010)
8th FHH standing committee meeting note
Admin
208
8th FSC 18 (2010)
Report the alert system for adulterated herbal medicines
-
Hong Kong SAR, China
207
8th FSC 17 (2010)
Chinese medicinal processing, a unique issue in the standardization of chinese materia medica
Zhongzhen ZHAO
Hong Kong SAR, China
206
8th FSC 16 (2010)
An introduction to ADR in China mainland(2009-2010)
Jieming ZHOU
China
55
56
57
58
59
60
61
62
63
